ストックスクリーナーアプリを入手
53.50
1.05%
-0.5403
前日終値:
$54.04
開ける：
$53.99
24時間の取引高:
423.19K
Relative Volume:
0.27
時価総額：
$7.24B
収益：
$2.51B
当期純損益:
$185.56M
株価収益率:
39.93
EPS:
1.34
ネットキャッシュフロー:
$517.59M
1週間 パフォーマンス:
-7.09%
1か月 パフォーマンス:
-8.85%
6か月 パフォーマンス:
-42.41%
1年 パフォーマンス:
-26.41%
1日の値動き範囲:
$53.39
$54.50
1週間の範囲:
$51.87
$57.99
52週間の値動き範囲:
$51.87
$94.93
Globus Medical Inc Stock (GMED) Company Profile
名前
Globus Medical Inc
セクター
電話
610-930-1800
住所
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA
GMED を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GMED
Globus Medical Inc
|
53.47 | 7.18B | 2.51B | 185.56M | 517.59M | 1.34 |
|
ABT
Abbott Laboratories
|
125.15 | 218.75B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
105.68 | 152.62B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
397.26 | 151.01B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
91.99 | 117.43B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
75.56 | 44.76B | 5.54B | 4.18B | 623.10M | 7.00 |
Globus Medical Inc Stock (GMED) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-27 | ダウングレード | BTIG Research | Buy → Neutral |
| 2025-01-10 | アップグレード | BofA Securities | Underperform → Neutral |
| 2024-12-02 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-07 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-05-20 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2024-03-18 | アップグレード | BTIG Research | Neutral → Buy |
| 2023-10-20 | 開始されました | ROTH MKM | Buy |
| 2023-09-19 | アップグレード | Stifel | Hold → Buy |
| 2023-03-30 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2023-02-13 | ダウングレード | BofA Securities | Buy → Underperform |
| 2023-02-10 | ダウングレード | BTIG Research | Buy → Neutral |
| 2023-02-10 | ダウングレード | Loop Capital | Buy → Hold |
| 2023-02-10 | ダウングレード | Needham | Buy → Hold |
| 2023-02-10 | ダウングレード | Truist | Buy → Hold |
| 2023-02-10 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2022-10-18 | 開始されました | Barclays | Overweight |
| 2022-10-12 | 開始されました | Jefferies | Buy |
| 2022-04-13 | 再開されました | Truist | Buy |
| 2022-03-28 | 開始されました | Wells Fargo | Overweight |
| 2022-01-04 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2021-12-13 | アップグレード | BofA Securities | Underperform → Buy |
| 2021-12-10 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-10-29 | 開始されました | Loop Capital | Buy |
| 2021-02-18 | 再開されました | Needham | Buy |
| 2020-12-08 | 開始されました | Citigroup | Buy |
| 2020-10-20 | 開始されました | Stifel | Hold |
| 2020-08-06 | 繰り返されました | Needham | Buy |
| 2020-08-06 | アップグレード | Northland Capital | Market Perform → Outperform |
| 2020-07-21 | 開始されました | Northland Capital | Market Perform |
| 2020-07-06 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2020-05-08 | 繰り返されました | Needham | Buy |
| 2020-03-18 | アップグレード | BTIG Research | Neutral → Buy |
| 2020-01-08 | 開始されました | SunTrust | Buy |
| 2019-12-12 | アップグレード | Wells Fargo | Market Perform → Outperform |
| 2019-08-02 | 繰り返されました | Needham | Buy |
| 2019-05-24 | ダウングレード | Wells Fargo | Outperform → Market Perform |
| 2019-05-03 | 繰り返されました | Needham | Buy |
| 2019-02-28 | アップグレード | UBS | Neutral → Buy |
| 2019-01-02 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2018-08-02 | 繰り返されました | Needham | Buy |
| 2018-06-27 | ダウングレード | BofA/Merrill | Neutral → Underperform |
| 2018-06-01 | 開始されました | Cantor Fitzgerald | Overweight |
| 2018-05-03 | 繰り返されました | Needham | Buy |
| 2018-04-04 | アップグレード | Needham | Hold → Buy |
すべてを表示
Globus Medical Inc (GMED) 最新ニュース
Orthobiologics Market Growth in Future Scope 2025-2032 | Zimmer Biomet, Bone Biologics Corp., Globus Medical - openPR.com
Globus Medical Names Keith Pfeil as CEO, Posts Strong Q2 Sales Growth - MSN
What analysts say about Globus Medical Inc. stockFree Predictions - jammulinksnews.com
Globus promotes Keith Pfeil to CEO as former exec leaves for Dentsply - MedTech Dive
Globus Medical Inc. Stock Analysis and ForecastFree Stock Market Mentorship - jammulinksnews.com
Is Globus Medical Inc. a good long term investmentBreakthrough wealth creation - jammulinksnews.com
Globus Medical to Announce Q2 2025 Financial Results on August 7, Followed by Investor Call - MSN
Spinal Non-Fusion Technologies Market Set to Witness - openPR.com
Globus Medical CEO leaves for Dentsply Sirona corner office - MassDevice
Globus Medical Appoints Keith Pfeil as CEO - citybiz
Avantor and Globus Medical appoint new CEOs - The Business Journals
What You Can Learn From Globus Medical, Inc.'s (NYSE:GMED) P/E - simplywall.st
Why Globus Medical (GMED) Shares Are Trading Lower Today - Yahoo Finance
Globus Medical stock holds steady as Needham maintains rating amid CEO change - Investing.com Canada
Globus CEO leaving, analysts see replacement as steady hand - BioWorld MedTech
Globus Medical's Leadership Transition: A Strategic Catalyst for Long-Term Growth in the Medical Technology Sector - AInvest
Globus Medical's Leadership Transition and Growth Potential in a Post-Merger Landscape - AInvest
Globus Medical stock hits 52-week low at 53.54 USD By Investing.com - Investing.com Canada
Daniel Scavilla Named CEO of Dentsply Sirona - Dentistry Today
Dentsply Sirona Hires Globus CEO Daniel Scavilla as Chief Exec - Medical Product Outsourcing
Impingement Syndrome Market Growing with Musculoskeletal - openPR.com
Globus Medical Announces New CEO and CFO - TipRanks
Globus Medical appoints Keith Pfeil as new CEO, reports Q2 sales growth By Investing.com - Investing.com South Africa
Dentsply Sirona Appoints Daniel Scavilla as President and CEO, Effective August 1, 2025 - Quiver Quantitative
Globus Medical sees Q2 revenue $745.3M, consensus $738.91M - TipRanks
Globus Medical (GMED) Posts Strong Sales Growth in Q2 2025 | GME - GuruFocus
Former Globus Medical CEO Takes Helm at Dentsply Sirona as Q2 Sales Hit $935M - Stock Titan
Globus Medical's Leadership Transition and Q2 Sales Performance: A Strategic Blueprint for Sustained Growth in Musculoskeletal Tech - AInvest
Globus Medical appoints Keith Pfeil as new CEO, reports Q2 sales growth - Investing.com
Globus Medical Expands Surgical Navigation Portfolio With Advanced DuraPro Oscillating System - MSN
GMED names new CEO & CFO after sudden resignation – compensation, details - Stock Titan
Globus Medical Announces Leadership Transitions and Preliminary Second Quarter 2025 Sales Results - GlobeNewswire
Globus Medical Shakes Up Leadership: New CEO Takes Helm as Q2 Sales Hit Record $745M, Up 18% - Stock Titan
What drives Globus Medical Inc. stock priceUnbelievable profit margins - printweek.in
GMED Unveils Next-Gen Oscillating System DuraPro: Stock to Gain? - MSN
Carlsmed seeks up to $103M IPO haul to fuel spine surgery growth - MedTech Dive
RBC Capital Reaffirms Their Buy Rating on Globus Medical (GMED) - The Globe and Mail
Globus Medical Schedules Second Quarter Earnings Release and Conference Call | GMED Stock News - GuruFocus
Globus Medical, Inc. to Announce Second Quarter 2025 Financial Results on August 7, 2025 - Nasdaq
Globus Medical Schedules Second Quarter Earnings Release and Conference Call - GlobeNewswire
Globus Medical Q2 Earnings Coming August 7: Key Focus on Musculoskeletal Tech Growth - Stock Titan
Globus Medical (GMED) Fell 19% in Q2 - MSN
Piper Sandler Maintained a Buy Rating on Globus Medical (GMED), Kept the PT Unchanged - Insider Monkey
Globus Medical Inc (GMED) 財務データ
収益
当期純利益
現金流量
EPS
0.09%
1.77%
大文字化:
|
ボリューム (24 時間):